- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/12 - Mumps virusMeasles virus
Patent holdings for IPC class C07K 14/12
Total number of patents in this class: 58
10-year publication summary
|
4
|
3
|
1
|
2
|
7
|
5
|
3
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Adaptimmune Limited | 163 |
4 |
| Immunocore Limited | 232 |
4 |
| Centre National de La Recherche Scientifique | 10899 |
3 |
| The Trustees of Columbia University in the City of New York | 3636 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3331 |
3 |
| The General Hospital Corporation | 4844 |
2 |
| The Broad Institute, Inc. | 1946 |
2 |
| Institut Curie | 609 |
2 |
| Institut Pasteur | 787 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2979 |
2 |
| Mnemo Therapeutics | 33 |
2 |
| Beijing Cell-fusion Biotechnology Co., Ltd. | 6 |
2 |
| Shanghai King-cell Biotechnology Co. Ltd. | 6 |
2 |
| F. Hoffmann-La Roche AG | 7847 |
1 |
| Pfizer Inc. | 3374 |
1 |
| Wisconsin Alumni Research Foundation | 3920 |
1 |
| The Johns Hopkins University | 5837 |
1 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11015 |
1 |
| Georgia Tech Research Corporation | 2912 |
1 |
| Mayo Foundation for Medical Education and Research | 3354 |
1 |
| Other owners | 18 |